MedTrace Logo

Helmet Non-Invasive Ventilation for COVID-19 Patients

NCT04477668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 322

Last updated 2022-09-09

No results posted yet for this study

Summary

Study hypothesis: Non-invasive positive pressure ventilation delivered by helmet will reduce 28-day all-cause mortality in patients with suspected or confirmed severe COVID-19 pneumonia and acute hypoxemic respiratory failure

Conditions

  • COVID-19
  • Acute Hypoxemic Respiratory Failure

Interventions

DEVICE

Helmet non-invasive ventilation

Patients will be allocated to helmet non-invasive ventilation

Sponsors & Collaborators

  • King Abdulaziz Medical City, Riyadh, Saudi Arabia

    collaborator UNKNOWN

  • King Fahd Hospital of the University, Al Khobar, Saudi Arabia

    collaborator UNKNOWN

  • Aseer Central Hospital, Abha, Saudi Arabia

    collaborator UNKNOWN

  • King Faisal Specialist Hospital & Research Center

    collaborator OTHER

  • King Fahad Hospital, Madinah, Saudi Arabia

    collaborator UNKNOWN

  • Al Amiri Hospital, Kuwait

    collaborator UNKNOWN

  • King Abdulaziz University

    collaborator OTHER

  • King Saud Medical City

    collaborator OTHER_GOV

  • King Abdullah International Medical Research Center

    lead OTHER

Principal Investigators

  • Yaseen Arabi, MD · King Abdulaziz Medical City - Riyadh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2021-11-16
Completion
2022-06-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04477668 on ClinicalTrials.gov